1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enochian Biosciences Inc (ENOB)
  7. News

ENOB

Enochian Biosciences News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Enochian Biosciences Inc ENOB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.45% 8.98 18:00:05
Open Price Low Price High Price Close Price Prev Close
8.98 8.83 9.15 8.98 8.94
more quote information »

Recent News

Date Time Source Heading
10/20/202112:45IHNWFeaturedGREENBANK PORTFOLIO COMPANY CODIKOAT ACHIEVES OUTSTANDING TRIAL RESULTS FOR ITS ANTI-VIRAL COATING PRODUCT
10/20/20218:00IHNWFeaturedGraphite to follow in lithium's footsteps
10/18/202107:00GLOBEEnochian BioSciences Announces the Successful Completion of..
10/15/202118:00GLOBEScientific Advisory Board Member Resigns Due to Conflict..
10/12/202118:00GLOBEFireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul..
9/27/202107:00GLOBEEnochian BioSciences Announces Its Successful Completion..
9/24/202117:28EDGARAnnual Report (10-k)
9/13/202108:16EDGARCurrent Report Filing (8-k)
9/13/202107:00GLOBEEnochian BioSciences to Present to Investors at the H.C...
8/30/202113:35EDGARCurrent Report Filing (8-k)
8/30/202107:00GLOBEDistinguished Scientific and Public Health Leaders to Join..
8/23/202110:18GLOBEDistinguished Scientific and Clinical Leader to Join..
7/23/202116:29EDGARCurrent Report Filing (8-k)
7/20/202107:54SEEKEnochian BioSciences picks Hon. Dr. Mark Dybul as CEO
7/20/202107:00GLOBEEnochian BioSciences Names The Hon. Dr. Mark Dybul as Chief..
7/12/202107:44SEEKEnochian Biosciences shares rise after FDA accepts hepatitis..
7/12/202107:00GLOBEEnochian BioSciences Announces FDA Acceptance of Pre-IND..
6/30/202107:00GLOBEEnochian BioSciences Announces Scientific Presentation of..
6/25/202111:50EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202107:00GLOBEEnochian BioSciences Announces Acquisition of Exclusive..
6/16/202116:10EDGARCurrent Report Filing (8-k)
6/16/202108:50EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/15/202109:05PRNUSPioneering Research Institute In Los Angeles Moves One Step..
6/14/202117:16EDGARInitial Statement of Beneficial Ownership (3)
6/14/202114:53GLOBEEnochian BioSciences Announces $29 Million Registered Direct..
6/14/202108:09SEEKEnochian Biosciences shares skyrocket after FDA accepts..
6/14/202107:00GLOBEEnochian BioSciences Announces FDA Acceptance of Pre-IND..
5/17/202116:46EDGARQuarterly Report (10-q)
5/12/202109:57SEEKEnochian Bio reports preliminary data from HIV cell therapy..
5/12/202108:05PRNUSA Promising Approach To HIV Cell Therapy, With Exciting..
5/12/202108:00GLOBEEnochian BioSciences announces Scientific Presentation of a..
4/22/202117:02EDGARCurrent Report Filing (8-k)
4/16/202117:01EDGARCurrent Report Filing (8-k)
3/25/202107:32SEEKEnochian Bio rallies 29% on case report of complete..
3/24/202118:00GLOBESeraph Research Institute and Enochian BioSciences Publish a..
3/24/202117:01EDGARCurrent Report Filing (8-k)
3/10/202116:34EDGARCurrent Report Filing (8-k)
3/09/202107:01EDGARCurrent Report Filing (8-k)
2/22/202117:15GLOBEEnochian BioSciences to Present to Investors at the H.C...
2/16/202116:27EDGARQuarterly Report (10-q)
2/11/202112:54EDGARRevised Proxy Soliciting Materials (definitive) (defr14a)
2/03/202117:09EDGARProxy Statement (definitive) (def 14a)
12/16/202014:03EDGARStatement of Changes in Beneficial Ownership (4)
12/16/202014:01EDGARStatement of Changes in Beneficial Ownership (4)
11/12/202017:30EDGARQuarterly Report (10-q)
10/28/202016:37EDGARAmended Annual Report (10-k/a)
See more news about this stock »


Your Recent History
NASDAQ
ENOB
Enochian B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.